About Sphingomyelin synthase-related protein 1
Sphingomyelin synthase-related protein 1 (SAMD8) is a protein
from Homo sapiens identified by UniProt accession
Q96LT4, 415 residues long.
MolForge cross-references it against 0 known binders and
33 disease associations.
Target properties
| Protein name | Sphingomyelin synthase-related protein 1 |
| UniProt accession | Q96LT4 |
| Gene | SAMD8 |
| Organism | Homo sapiens |
| Length | 415 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (33)
Diseases linked to this target (Open Targets).
- self reported educational attainment · score 0.30
- blood protein measurement · score 0.24
- unipolar depression · score 0.23
- body mass index · score 0.23
- refractive error measurement · score 0.23
- smoking status measurement · score 0.23
- smoking initiation · score 0.23
- body fat percentage · score 0.13
- high density lipoprotein cholesterol measurement · score 0.12
- insomnia measurement · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96LT4-F1 | alphafold | PREDICTED | 79.48 | — |
Amino-acid sequence (415 residues)
MAGPNQLCIR RWTTKHVAVW LKDEGFFEYV DILCNKHRLD GITLLTLTEY DLRSPPLEIK VLGDIKRLML SVRKLQKIHI DVLEEMGYNS DSPMGSMTPF ISALQSTDWL CNGELSHDCD GPITDLNSDQ YQYMNGKNKH SVRRLDPEYW KTILSCIYVF IVFGFTSFIM VIVHERVPDM QTYPPLPDIF LDSVPRIPWA FAMTEVCGMI LCYIWLLVLL LHKHRSILLR RLCSLMGTVF LLRCFTMFVT SLSVPGQHLQ CTGKIYGSVW EKLHRAFAIW SGFGMTLTGV HTCGDYMFSG HTVVLTMLNF FVTEYTPRSW NFLHTLSWVL NLFGIFFILA AHEHYSIDVF IAFYITTRLF LYYHTLANTR AYQQSRRARI WFPMFSFFEC NVNGTVPNEY CWPFSKPAIM KRLIG
Explore Sphingomyelin synthase-related protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets